Entrar/Registro  
INICIO ENGLISH
 
Enfermedades Infecciosas y Microbiología
   
MENÚ

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor

Directorio






>Revistas >Enfermedades Infecciosas y Microbiología >Año 2007, No. 2


Cruz GE, Díaz PH
Modificación de la microbiota intestinal en recién nacidos atendidos en las UCINs: nueva estrategia para disminuir las infecciones nosocomiales
Enf Infec Microbiol 2007; 27 (2)

Idioma: Español
Referencias bibliográficas: 43
Paginas: 55-59
Archivo PDF: 117.08 Kb.


Texto completo




RESUMEN

Las altas tasas de morbilidad y mortalidad atribuidas a infecciones nosocomiales son un problema observado en las UCINs de todo el mundo. Los agentes causales de estas infecciones inicialmente colonizan al hospedero; la colonización del tracto digestivo con bacterias multirresistentes es una de las etapas que dan origen a tales infecciones, ya que constituye un reservorio natural en el ambiente hospitalario.
El uso de probióticos orales podría ser una alternativa para modificar la colonización del tracto intestinal, debido a que es simple de administrar, no es invasiva, no implica el uso de antibióticos, favorecen mecanismos de defensa natural del tubo digestivo. Sin embargo, hasta el momento falta evidencia científica para recomendar el uso de probióticos orales en recién nacidos como una estrategia para disminuir la colonización intestinal por bacterias patógenas.


Palabras clave: infecciones nosocomiales, bacterias multirresistentes, colonización intestinal, probióticos orales, microbiota.


REFERENCIAS

  1. Bisson G, Neil O, Badaus J. Extended spectrum beta lactamase- producing Escherichia Coli and Klebsiella species: Risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidemiol 2002; 23: 254-260.

  2. Baquero F, Negri MC, Morosini MI. Antibiotic-selective environments. CID 1998; 27: S5-11.

  3. Díaz Ramos R, Solórzano Santos F, Padilla Barrón G y cols. Infecciones nosocomiales. Experiencia en un hospital pediátrico de tercer nivel. Salud Pública Méx 1999; 41: S12-17.

  4. Departamento de Epidemiología. Registro 2006 Hospital de Pediatría Centro Médico Nacional. Siglo XXI.

  5. Karlowicz MG, Buescher ES, Surka AE. Fulminant lateonset sepsis in a neonatal intensive care unit. 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000; 106: 1387-1390.

  6. Donskey CJ. The role of de intestinal tract as a reservoir and source for transmition of nosocomial pathogens. CID 2004; 39: 219-226.

  7. Gray JE, Richardson DK, Mc Cormick MC. Coagulasenegative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use and outcome. Pediatrics 1995; 95: 225-230.

  8. Peregrino BP, Villegas SR, Fortino SS, Miranda NG. Cefalotina y amikacina para tratamiento de sepsis neonatal de adquisición nosocomial en una Unidad de Cuidados Intensivos Neonatales. Bol Med Hosp Infant Méx. 2004; 61: 394-401.

  9. Cardero L, Raur R, Taylor D. Enteric gram-negative bacilli bloodstream infections: 17 years experience in neonatal UCI. Am J Infect Control 2004; 3232(14): 189-195.

  10. Eriksson M, Melen M, Myrback KE, Winblandh B, Zatterstrom R. Bacterial colonization of newborn infants in a neonatal intensive care unit. Acta Paediatr Scand 1982; 71: 779-783.

  11. Liberati A, Brazzi L, Torri V. Meta-Analysis of Randomized Controlled Trials of Selective Decontamination of the Digestive Tract. BMJ 1993; 307: 525-532.

  12. Seppo S, Isolauri E. Intestinal colonization microbiota and probiotics. J Pediatr 2006; 149: 5115-5120.

  13. International Human Genome Sequencing Consortion. Initial sequencing and analysis of human genome. Nature 2001; 409: 860-921.

  14. Backhed F, Ley RE, Sonnenburg JL. Host bacterial mutualism in the human intestine. Science 2005; 307: 1915-1920.

  15. Grunulund MM, Aruilummi H, Kero P. Importance of intestinal colonization in the maturation of humoral immunity in early infancy: a prospective follow-up study of healthy infants aged 0-6 months. Arch Dis Child 2000; 83: F186-192.

  16. Harmsen HJ, Widebuer-Velou AC. Raung GC, Wagendorp A. Analysis of intestinal flora development in breastfed and formula-feeding by using molecular identification and detection methods. J Pediatr Gastroenteral Nutr 2000; 30: 61-67

  17. Hoy CM. The role of infection in necrotizing enterocolitis. Rev Med Microbiol 2002; 121-129.

  18. Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J 2000; 19: 319-324.

  19. Benjamin DK, Stoll BJ, Fanaroff AA. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006; 117: 84-92.

  20. Saiman L, Ludington E, Dawson JD, et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 2001; 20: 1119-1124.

  21. Haung YC, Li CC, Lin TY, et al. Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect Dis J 1998;17: 89-22.

  22. Donstkey CJ. Antibiotic Regimens and Intestinal Colonization with Antibiotic-Resistant Gram-Negative Bacilli. CID 2006: 43; S62-69.

  23. Bonnet M, Kullberg B, van Dalen R, Girbes J, Hoepelman M. Selective digestive decontamination in patients in intensive care. JAC 2000; 46: 351-362.

  24. Jonge E, Schultz M, Spanjard L, et al. Effects of selective decontamination of digestive tract on mortality and adquisition of resistant bacteria in intensive care: a randomized controlled trail. Lancet 2003; 362: 1011-1016.

  25. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115: 1-4.

  26. Kitajima H, Sumida Y, Tanaka R, et al. Early administration of Bifidobacterium breve to preterm infants; randomized controlled trial. Arch Dis Child Fetal Neonatal 1997; 70: F101-F107.

  27. Dani C, Bradaroli R, Bertinni G, Martelli E. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. Biol Neonate 2002; 82: 103-108.

  28. Salminen S, Bouley C, Bouton RM, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; S147-171.

  29. Que JU, Caset SW, Hetge DJ. Factor responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin. Infect Immun 1986; 53: 116-123.

  30. Millar M, Wilkes M. Probiotics for preterm infants? Arch Dis Child Fetal Neonatal 2003; 88: F354-F358.

  31. Rakoff-Nhown S, Paglino J. Recognition of commensal microflora by toll-like receptor is required for intestinal homeostasis. Cell 2004; 118: 229-241.

  32. Caplan MS, Miller R, Kaup S. Russell T, et al. Bifidobacterial Supplementation Reduces the Incidence of Necrotizing Enterocolitis in a Neonatal Rat Model. Gastroenterology 1999; 117: 577-583.

  33. Petschowr BW, Figueroa R, Harris CL, et al. Effects of feeding an infant formula containing Lactobacillus GG on the colonization of the intestine: a dose response study in healthy infants. J Clin Gastroenterol 2005; 39: 786-790.

  34. Manzoni P, Mostert M, Leonessa L, Priolo C, Farina D. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a Randomized Study. CID. 2006; 42: 1735-1742.

  35. Agarwal R, Sharma N, Chaudhry R, Deorari A. Effects of oral Lactobacillus GG on enteric microflora in low- birthweight neonates. J Pediatrc Gastroenterol Nutr 2003; 36: 397-402.

  36. Hammerman C, Kaplan M. Probiotics and neonatal intestinal infection. Curr Opin Infect Dis 2006; 19: 277-282.

  37. Saxelin M, Chuang NH, Chassy B, et al. Lactobacilli and bacteremia in Southern Finland, 1892-1992. CID 1996; 22: 564-565.

  38. Broughton RA, Grober WG, Haffar AA. Neonatal Meningitis due to Lactobacillus. Pediatr Infect Dis J 1983; 2: 282-384.

  39. Van Neil CW, Feudtner C, Garrison MM. Lactobacillus therapy for acute infectious diarrhea in children: a metaanalysis. Pediatrics 2002; 109: 678-684.

  40. Land MH, Rouster K, Woods CR, et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005; 115: 178-181.

  41. Petschow BW, Figueroa R, Harris C, Beck L. Effects of feeding and Infant formula containing Lactobacillus GG on the colonization of the intestine. A dose- response study in healthy infants. J Clin Gastroenterol 2005; 39: 786-790.

  42. Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen T. Persistente of colonization of human colonic mucosa by a probiotic stain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 1999; 65: 351-354.

  43. Gopal P, Prasad J, Smart J, Gill H. In vitro adherence properties of Lactobacillus rhamnosus DR, and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotixigenic Escherichia coli. Int J Food Microbiol 2001; 65: 207-216.



>Revistas >Enfermedades Infecciosas y Microbiología >Año2007, No. 2
 

· Indice de Publicaciones 
· ligas de Interes 






       
Derechos Resevados 2019